MR spectroscopy shows metabolic changes in transgenic Huntington's disease mice

被引：0
|
作者：
Andreassen, OA
Jenkins, BG
Kuesterman, E
Dedeoglu, A
Hayden, MR
Ross, CA
Borchelt, DR
Beal, MF
机构：
[1] HMS, MGH, NMR Ctr, Boston, MA USA
[2] Bedford VA Med Ctr, GRECC, Bedford, MA USA
[3] Univ British Columbia, Dept Neurol, Vancouver, BC, Canada
[4] Johns Hopkins, Dept Psych Neur, Baltimore, MD USA
[5] Cornell Med Ctr, Dept Neurol, New York, NY USA
[6] Ullueval Univ Hosp, Oslo, Norway
来源：
NORDIC JOURNAL OF PSYCHIATRY | 2005年 / 59卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：405 / 405
页数：1
相关论文
共 50 条
  • [11] Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice
    Dickson, Elna
    Soylu-Kucharz, Rana
    Petersen, Asa
    Bjorkqvist, Maria
    [J]. MOLECULAR METABOLISM, 2022, 57
  • [12] Evaluation of treatment stategies for Huntington's disease in transgenic mice
    Schiefer, J
    Lüesse, HG
    Sprünken, A
    Puls, C
    Milkereit, A
    Milkereit, E
    Kosinski, CM
    [J]. ACTA NEUROPATHOLOGICA, 2002, 104 (05) : 568 - 568
  • [13] A comprehensive glycome profiling of Huntington's disease transgenic mice
    Gizaw, Solomon T.
    Koda, Toshiaki
    Amano, Maho
    Kamimura, Keiko
    Ohashi, Tetsu
    Hinou, Hiroshi
    Nishimura, Shin-Ichiro
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2015, 1850 (09): : 1704 - 1718
  • [14] Structural and metabolic changes in Huntington's disease brain
    Squitieri, F
    Cannella, M
    Rubinsztein, DC
    Frati, L
    Lastoria, S
    Ciarmiello, A
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [15] Striatal neurochemical changes in transgenic models of Huntington's disease
    Ariano, MA
    Aronin, N
    Difiglia, M
    Tagle, DA
    Sibley, DR
    Leavitt, BR
    Hayden, MR
    Levine, MS
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 68 (06) : 716 - 729
  • [16] Metabolic disruption identified in the Huntington’s disease transgenic sheep model
    Renee. R. Handley
    Suzanne J. Reid
    Stefano Patassini
    Skye R. Rudiger
    Vladimir Obolonkin
    Clive. J. McLaughlan
    Jessie C. Jacobsen
    James F. Gusella
    Marcy E. MacDonald
    Henry J. Waldvogel
    C. Simon Bawden
    Richard L. M. Faull
    Russell G. Snell
    [J]. Scientific Reports, 6
  • [17] Metabolic disruption identified in the Huntington's disease transgenic sheep model
    Handley, Renee. R.
    Reid, Suzanne J.
    Patassini, Stefano
    Rudiger, Skye R.
    Obolonkin, Vladimir
    McLaughlan, Clive. J.
    Jacobsen, Jessie C.
    Gusella, James F.
    MacDonald, Marcy E.
    Waldvogel, Henry J.
    Bawden, C. Simon
    Faull, Richard L. M.
    Snell, Russell G.
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [18] Mice transgenic for exon 1 of Huntington's disease: changes in modulation of dopamine and acetylcholine release in the striatum
    Vetter, J. M.
    Jehle, T.
    Aranda, H.
    Franz, P.
    Behrens, P. F.
    Jackisch, R.
    Landwehrmeyer, G. B.
    Feuerstein, T. J.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 116 - 116
  • [19] Somatostatin Receptor 1 and 5 Double Knockout Mice Mimic Neurochemical Changes of Huntington's Disease Transgenic Mice
    Rajput, Padmesh S.
    Kharmate, Geetanjali
    Norman, Michael
    Liu, Shi-He
    Sastry, Bhagavatula R.
    Brunicardi, Charles F.
    Kumar, Ujendra
    [J]. PLOS ONE, 2011, 6 (09):
  • [20] The use of transgenic and knock-in mice to study Huntington's disease
    Hickey, MA
    Chesselet, MF
    [J]. CYTOGENETIC AND GENOME RESEARCH, 2003, 100 (1-4) : 276 - 286
12345